NEW YORK (Reuters Health) – The lipid-modifying effects of rosuvastatin (Crestor: AstraZeneca) are stronger than atorvastatin (Lipitor; Pfizer) in patients with an acute coronary syndrome (ACS), according to…
NEW YORK (Reuters Health) – The reduced risk of developing invasive breast cancer with adjuvant tamoxifen therapy after lumpectomy and radiation for ductal carcinoma in situ (DCIS) is…
NEW YORK (Reuters Health) – When antiepileptic drug therapy fails to control disabling temporal lobe epilepsy adequately, patients have a much better chance of becoming seizure free with…
NEW YORK (Reuters Health) – A new analysis of pooled data on omalizumab should help allay concerns that omalizumab (Xolair; Genentech, Novartis) may increase the risk for cancer.…
NEW YORK (Reuters Health) – Iron-deficiency anemia can lead to high glycosylated hemoglobin (HbA1c) concentrations that do not reflect glycemic parameters, an Indian study has shown. “The use…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, glycemic control is better and weight loss is sustained up to 84 weeks with exenatide once weekly…
NEW YORK (Reuters Health) – Malnourished adults aged 60 and older who started an energy- and protein-enriched nutritional plan plus calcium and vitamin D supplements following hospital discharge…
NEW YORK (Reuters Health) – Giving the probiotic Lactobacillus reuteri DSM 17938 to hospitalized children is unlikely to protect them from nosocomial diarrhea, including rotavirus infection, according to…
NEW YORK (Reuters Health) – Increases in fasting blood sugar levels are often seen in patients starting niacin, sometimes to a level that suggests new onset of type…
NEW YORK (Reuters Health) – Adding trimetazidine to the treatment of chronic heart failure improves cardiac function and slows left ventricular remodeling, according to the results of a…
